HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway.

Abstract
EBERs (EBER1 and EBER2) are suggested to be involved in cellular transformation and tumor growth. Cytoplasmic pattern recognition receptor-RIG-I, which is characterized by the recognition of viral dsRNAs, could efficiently trigger the downstream pathways of innate immunity. Although some previous reports have shown that EBERs and RIG-I associate with hematological malignancies, the role of EBERs-RIG-I signaling in solid tumors remains to be clarified. Here we demonstrate that EBER mediation of the inflammatory response via RIG-I contributes to NPC development in vitro and in vivo. We first verified that the expression level of RIG-I was associated with EBER transcription in a dose-dependent manner in NPC cells and specimens from NPC patients. Furthermore, pro-inflammatory cytokine transcription and release were sharply reduced after RIG-I knockdown compared with the control shRNA group in the presence of EBERs, accompanied by an attenuation of the NF-κB and MAPK signaling pathways. Consequently, the tumor burden was greatly alleviated in the RIG-I knockdown group in a xenograft model. In addition, macrophage colony-stimulating factor (M-CSF) and monocyte chemoattractant protein (MCP-1), which promote the maturation and attraction of tumor-associated macrophages, were stimulated upon the introduction of EBERs, and this upregulation conceivably led to the tumor-promoting subset transition of the macrophages. Taken together, our results reveal that EBERs could promote NPC progression through RIG-I-mediated cancer-related inflammation.
AuthorsYumei Duan, Zhi Li, Shiyue Cheng, Yan Chen, Lu Zhang, Jiang He, Qiong Liao, Lifang Yang, Zhicheng Gong, Lun-Quan Sun
JournalCancer letters (Cancer Lett) Vol. 361 Issue 1 Pg. 67-74 (May 28 2015) ISSN: 1872-7980 [Electronic] Ireland
PMID25721089 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Cytokines
  • Epstein-Barr virus encoded RNA 1
  • Epstein-Barr virus encoded RNA 2
  • IRF3 protein, human
  • Inflammation Mediators
  • Interferon Regulatory Factor-3
  • NF-kappa B
  • RNA, Messenger
  • RNA, Small Interfering
  • RNA, Viral
  • Receptors, Immunologic
  • DDX58 protein, human
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases
Topics
  • Animals
  • Blotting, Western
  • Carcinoma
  • Cell Differentiation
  • Coculture Techniques
  • Cytokines (genetics, metabolism)
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases (antagonists & inhibitors, genetics, metabolism)
  • Disease Progression
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Immunoprecipitation
  • Inflammation (immunology, metabolism, pathology)
  • Inflammation Mediators (analysis)
  • Interferon Regulatory Factor-3 (genetics, metabolism)
  • Macrophages (immunology, metabolism, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • NF-kappa B (genetics, metabolism)
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms (immunology, metabolism, pathology)
  • RNA, Messenger (genetics)
  • RNA, Small Interfering (genetics)
  • RNA, Viral (antagonists & inhibitors, genetics, metabolism)
  • Real-Time Polymerase Chain Reaction
  • Receptors, Immunologic
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured
  • Tumor Microenvironment
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: